Cargando…
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
Molecular mimicry is one of the leading mechanisms by which infectious agents can induce autoimmunity. Whether a similar mechanism triggers an antitumor immune response is unexplored, and the role of antiviral T cells infiltrating the tumor has remained anecdotal. To address these questions, we firs...
Autores principales: | Chiaro, Jacopo, Kasanen, Henna H.E., Whalley, Thomas, Capasso, Cristian, Grönholm, Mikaela, Feola, Sara, Peltonen, Karita, Hamdan, Firas, Hernberg, Micaela, Mäkelä, Siru, Karhapää, Hanna, Brown, Paul E., Martins, Beatriz, Fusciello, Manlio, Ylösmäki, Erkko O., Greco, Dario, Kreutzman, Anna S., Mustjoki, Satu, Szomolay, Barbara, Cerullo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974425/ https://www.ncbi.nlm.nih.gov/pubmed/34103348 http://dx.doi.org/10.1158/2326-6066.CIR-20-0814 |
Ejemplares similares
-
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2021) -
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2023) -
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients
por: Kasanen, Henna, et al.
Publicado: (2020) -
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
por: Hamdan, Firas, et al.
Publicado: (2021) -
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy
por: Ylösmäki, Leena, et al.
Publicado: (2019)